Skip to main content
. Author manuscript; available in PMC: 2021 Oct 19.
Published in final edited form as: J Invest Dermatol. 2020 Apr;140(4):723–728.e1. doi: 10.1016/j.jid.2020.01.018

Table 1.

Key Considerations When Performing a CRISPR-ko Screen

Screen Phase Considerations Advantages/Disadvantages
I. Targets
 What genes will be studied?
Choice of library • Genome-scale libraries have the benefit of being comprehensive but can be resource-intensive. Predesigned genome-wide CRISPR libraries are available
• Targeted libraries focus on class of elements (kinases, transcription factors, etc.) or can be custom-designed and generated by the investigator
II. Model
 What cells should be used?
Cas9 expression • Primary cells require delivery of both Cas9 and sgRNA, which may be technically challenging
• Stably expressing Cas9 cell lines provide uniform high expression of Cas9
III. Assay
 How are cells screened?
Phenotype • A classical screen results in positive or negative selection from a selective pressure (e.g., exposure to a drug)
• Combining CRISPR screens with other genetic tools such as reporter cell lines can facilitate screening for diverse phenotypes
IV. Analysis
 How are screen results evaluated?
Measuring screen outputs • Changes in sgRNA abundance, measured by next-generation sequencing, are a classical output of CRISPR-ko screens
• A variety of validated CRISPR screen analysis pipelines are publicly available

Abbreviations: CRISPR-ko, CRISPR knockout; sgRNA, single guide RNA.